6 completed. 2 Phase 2, 2 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 4 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow epaxal berna: new trials by email Literature Review of epaxal berna trials Research Report on epaxal berna
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety of Vaccinations in Immunocompromised Persons Hepatitis A vaccine and tetanus vaccine - Arthritis, Rheumatoid, Spondylarthritis | Completed | University of Zurich | 645 | 2013-10-01 | 2016-02-25 | |
| PCV13 + Hepatitis A Vaccine for Adults Prevenar13, Hepatitis A vaccine - Measurement of Immune Response to Prevenar13, Measurement of Immune Response to Hepatitis A | Phase 4 | Completed | Helsinki University Central Hospital | 305 | 2013-08-24 | 2024-12-05 |
| Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients Epaxal Berna (virosomal hepatitis A vaccine) - Inflammatory Bowel Disease, Crohn's Disease | Phase 4 | Completed | Asan Medical Center | 493 | 2011-04-01 | 2013-03-19 |
| Hepatitis A Vaccine in Patients With Immunomodulating Drugs hepatitis A vaccine ( HAVRIX or EPAXAL) - Response to Hepatitis A Vaccine | Phase 2 | Completed | Lars Rombo | 68 | 2009-09-01 | 2015-11-18 |
| Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines Epaxal, Havrix 720 - Hepatitis A | Phase 3 | Completed | Crucell Holland BV | 327 | 2007-03-14 | 2019-04-08 |
| Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine Epaxal 0.25 mL, Epaxal 0.5 mL, Havrix Junior 0.5 mL - Hepatitis A | Phase 2 | Completed | Crucell Holland BV | 308 | 2004-06-01 | 2014-07-29 |
Hepatitis (3) · Hepatitis A (3) · Arthritis, Rheumatoid (2) · Colitis, Ulcerative (1) · Crohn Disease (1) · Inflammatory Bowel Diseases (1) · Spondylarthritis (1) · Vasculitis (1)
Crucell Holland BV (2) · Asan Medical Center (1) · Helsinki University Central Hospital (1) · Lars Rombo (1) · University of Zurich (1)
Finland (2) · Sweden (2) · Belgium (1) · Israel (1) · South Korea (1) · Switzerland (1)
Andre Vertruyen, MD (1) · Anu Kantele, Assoc. prof. (1) · Christoph Hatz, Professor (1) · Lars Rombo, Professor (1) · Pierre van Damme, MD (1) · Ron Dagan, MD (1) · Shai Ashkenazi, MD (1) · Suk-Kyun Yang, M.D. (1)